Search Results 1-10 of 16 for intestinal metaplasia

1. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

   Study IDs Site IRB Jacksonville, Florida: 14-000316 NCT ID: NCT02162758 Sponsor Protocol Number: DEX-P4-003 About this study This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal...

2. Using Laser Endomicroscopy to Predict Recurrence of Barrett's Esophagus - Mayo Clinic

   Overview Tab Title Description Study type Interventional Study IDs Study type Interventional Describes the nature of a clinical study. Types include: Observational study - observes people and measures outcomes without affecting results. Interventiona...

3. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

   Study IDs Site IRB Rochester, Minnesota: 19-007916 Sponsor Protocol Number: 19-007916 About this study The purpose of this study is to establish the mean concentration of duodenogastric refluxed bile acid in patients with recurrent Barrett's esophagu...

4. Screening strategies for prevalent esophageal adenocarcinoma may be different from those recommended for Barrett's esophagus - Mayo Clinic

   "Our results suggest the existence of an alternative pathway — one in which metaplasia progresses rapidly to EAC , with or without intestinal metaplasia," says Dr.

5. Gastrointestinal Neoplasia Clinic - Overview - Mayo Clinic

   oscopic or surgical management People at higher than average risk of gastrointestinal cancer, based on: Family history (including heritable syndromes) of gastrointestinal cancer or polyposis Past personal history of gastrointestinal cancer or pre-can...

6. Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? - Mayo Clinic

   Study IDs Site IRB Rochester, Minnesota: 09-007252 Sponsor Protocol Number: 09-007252 About this study The investigators hypothesize that intensive acid suppression with a long acting high potency proton pump inhibitor (dexlansoprazole) will lead to ...

7. Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus - Mayo Clinic

   Study IDs Site IRB Rochester, Minnesota: 18-005013 NCT ID: NCT03554356 Sponsor Protocol Number: 18-0388 About this study The purpose of this multicenter, prospective, single arm, non-randomized clinical trial to evaluate the safety and efficacy of th...

8. Young-onset esophageal adenocarcinoma: Results from a population-based study - Mayo Clinic

   "These cancers may undergo a more rapid transition from intestinal metaplasia to esophageal adenocarcinoma," explains Dr.

9. Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation - Mayo Clinic

   However, recurrence of intestinal metaplasia (IM) and dysplasia after successful ablation is well documented.

10. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett's Esophagus Rochester, MN The purpose of this study is to establish the mean concentration of duodenogastric refluxed bile acid in patients with recurrent Barrett's esophagus (BE...